Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Up – What’s Next?

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKYGet Free Report) gapped up prior to trading on Monday . The stock had previously closed at $21.37, but opened at $22.89. Daiichi Sankyo shares last traded at $22.48, with a volume of 31,502 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Zacks Research cut shares of Daiichi Sankyo from a “hold” rating to a “strong sell” rating in a research report on Wednesday, November 19th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Daiichi Sankyo has a consensus rating of “Moderate Buy”.

Check Out Our Latest Research Report on DSNKY

Daiichi Sankyo Price Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.60 and a current ratio of 2.31. The stock has a market cap of $42.68 billion and a PE ratio of 21.25. The business has a 50 day moving average price of $22.66 and a two-hundred day moving average price of $23.75.

Daiichi Sankyo Company Profile

(Get Free Report)

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.

Featured Stories

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.